Using the Cleaner XT Device for Pharmacomechanical Thrombolysis of Arteriovenous Fistulas and Grafts.

PURPOSE

The Cleaner XT (Argon Medical Device, Plano, TX) rotational thrombectomy (RT) device is an emerging treatment option for arteriovenous fistula (AVF) and graft revascularization. This study aims to report the procedural details, safety, efficacy, and patency of AVFs and grafts for endovascular salvage procedures conducted with the Cleaner XT device.

METHODS

All patients who underwent RT with the Cleaner XT RT System for endovascular salvage of AVFs and grafts from August 2016 to July 2022 at a single tertiary hospital were included. Study population, procedure, lesion characteristics, and the patency of AVFs and grafts after endovascular thrombectomy were reported.

RESULTS

Patency after endovascular salvage with Cleaner XT for all 13 patients was 84.6% (11/13) at one-month follow-up and 53.8% (7/13) for all follow-ups until 12 months.

CONCLUSION

This study shows that endovascular access salvage of AVF and graft with Cleaner XT is safe and demonstrates an excellent clinical and technical success rate.